tiprankstipranks
G2GBIO, Inc. (KR:456160)
:456160
South Korea Market

G2GBIO, Inc. (456160) Price & Analysis

Followers

456160 Stock Chart & Stats

₩26950.00
₩4,000.00(17.43%)
--

456160 FAQ

What was G2GBIO, Inc.’s price range in the past 12 months?
G2GBIO, Inc. lowest stock price was ₩22400.00 and its highest was ₩124000.00 in the past 12 months.
    What is G2GBIO, Inc.’s market cap?
    G2GBIO, Inc.’s market cap is ₩381.65B.
      When is G2GBIO, Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were G2GBIO, Inc.’s earnings last quarter?
      Currently, no data Available
      Is G2GBIO, Inc. overvalued?
      According to Wall Street analysts G2GBIO, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does G2GBIO, Inc. pay dividends?
        G2GBIO, Inc. does not currently pay dividends.
        What is G2GBIO, Inc.’s EPS estimate?
        G2GBIO, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does G2GBIO, Inc. have?
        G2GBIO, Inc. has 16,629,425 shares outstanding.
          What happened to G2GBIO, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of G2GBIO, Inc.?
          Currently, no hedge funds are holding shares in KR:456160
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            G2GBIO, Inc. (456160) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            GemVax & KAEL Co Ltd
            Medy-Tox Inc.
            AbClon, Inc.
            Inventage Lab, Inc.
            Onconic Therapeutics, Inc.
            Popular Stocks